113 related articles for article (PubMed ID: 14961029)
1. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program.
van der Velden VH; Boeckx N; Gonzalez M; Malec M; Barbany G; Lion T; Gottardi E; Pallisgaard N; Beillard E; Hop WC; Hoogeveen PG; Gabert J; van Dongen JJ;
Leukemia; 2004 Apr; 18(4):884-6. PubMed ID: 14961029
[No Abstract] [Full Text] [Related]
2. Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods.
Taube T; Eckert C; Körner G; Henze G; Seeger K
Leuk Res; 2004 Jul; 28(7):699-706. PubMed ID: 15158091
[TBL] [Abstract][Full Text] [Related]
3. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Gabert J; Beillard E; van der Velden VH; Bi W; Grimwade D; Pallisgaard N; Barbany G; Cazzaniga G; Cayuela JM; Cavé H; Pane F; Aerts JL; De Micheli D; Thirion X; Pradel V; González M; Viehmann S; Malec M; Saglio G; van Dongen JJ
Leukemia; 2003 Dec; 17(12):2318-57. PubMed ID: 14562125
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
Sedlácek P; Trka J; Zuna J; Hrusák O; Honzátková-Krsková L; Stary J
Haematologica; 2000 Oct; 85(10):1100-2. PubMed ID: 11025608
[No Abstract] [Full Text] [Related]
5. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
[TBL] [Abstract][Full Text] [Related]
6. TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL.
Fronkova E; Madzo J; Zuna J; Reznickova L; Muzikova K; Hrusak O; Stary J; Trka J
Leukemia; 2005 Jul; 19(7):1296-7. PubMed ID: 15858617
[No Abstract] [Full Text] [Related]
7. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.
Zhou MH; Gao L; Jing Y; Xu YY; Ding Y; Wang N; Wang W; Li MY; Han XP; Sun JZ; Wang LL; Yu L
Ann Hematol; 2012 Aug; 91(8):1235-43. PubMed ID: 22373549
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
9. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
10. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
[No Abstract] [Full Text] [Related]
11. Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol.
Prezeau N; Silvy M; Gabert J; Picard C
Leuk Res; 2006 May; 30(5):569-74. PubMed ID: 16209886
[TBL] [Abstract][Full Text] [Related]
12. Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Martinelli G; Buonamici S; Visani G; Malagola M; Piccaluga PP; Isidori A; Bosi C; Bonifazi F; Soverini S; Terragna C; Amabile M; Giannini B; Baccarani M
Leukemia; 2003 Mar; 17(3):650-1; author reply 651-2. PubMed ID: 12646962
[No Abstract] [Full Text] [Related]
13. Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin.
Zuna J; Zaliova M; Muzikova K; Meyer C; Lizcova L; Zemanova Z; Brezinova J; Votava F; Marschalek R; Stary J; Trka J
Genes Chromosomes Cancer; 2010 Oct; 49(10):873-84. PubMed ID: 20589932
[TBL] [Abstract][Full Text] [Related]
14. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
[TBL] [Abstract][Full Text] [Related]
15. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
16. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease detection in acute lymphoblastic leukemia: real improvement with the real-time quantitative PCR method?
Neale GA; Campana D; Pui CH
J Pediatr Hematol Oncol; 2003 Feb; 25(2):100-2. PubMed ID: 12571458
[No Abstract] [Full Text] [Related]
18. Detection of minimal residual disease in acute leukemia.
van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
[TBL] [Abstract][Full Text] [Related]
19. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
20. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
Alpár D; Kajtár B; Kneif M; Jáksó P; László R; Kereskai L; Pajor L
Cancer Genet Cytogenet; 2007 Feb; 173(1):23-30. PubMed ID: 17284366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
